Cannabis and Inflammatory Bowel Disease

Learn about cannabis for individuals living with Crohn's or colitis. Experts discuss the use of cannabis for intestinal disorders, gut inflammation, symptom management and what current research tells us about cannabis and IBD. Frequently asked questions are answered in this interactive webinar.


Dr. Keith Sharkey (Ph.D) is a Professor of Physiology and Pharmacology and Crohn's and Colitis Canada (CCC) Chair in IBD Research at the University of Calgary.

Dr. Yasmin Nasser (MD Ph.D. FRCPC) is a is a Clinical Assistant Professor in the Department of Medicine and a clinician-scientist in the Division of Gastroenterology and Hepatology at the University of Calgary.

This education presentation is supported by Canopy Growth
Canopy Growth Logo
Disclaimer: There is no scientific evidence that the use of medical marijuana in any form prevents IBD symptoms and Crohn's and Colitis Canada does not endorse the use of any cannabis product.

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest